[2020 TEIN/KOICA] Summer Workshop for Vietnam ( Session 4)

Value of the Information & Strength of the Argument

The value of the information is high for practitioners in nuclear medicine, as it provides concrete examples of QC failures and their consequences. The argumentation is based on real cases and practical experience, making it credible. However, the presentation is largely anecdotal and lacks systematic data analysis or references to scientific literature. The speakers do not provide a structured framework for QC but rather share experiences and best practices. The emphasis on understanding the meaning of TLC results and the importance of process QC is valuable. The argumentation is solid in that it demonstrates cause-and-effect relationships between QC failures and clinical outcomes, but it could be strengthened by more rigorous data presentation and comparison with established guidelines.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The speakers are experts from a reputable institution, and the cases are presented in detail. However, no external sources are cited, and the content is based on personal experience. The title accurately reflects the content, which is a workshop session on quality control. The presentation is well-structured, but the lack of references and formal data analysis reduces its scientific rigor. The speakers do mention the Korean Pharmacopoeia and USP, but they do not provide specific citations. Overall, the content is informative but would benefit from more rigorous scientific backing.

The title accurately reflects the content: a workshop session on quality control in nuclear medicine, specifically radiochemistry-based quality control.

7/10

The presentation is based on real clinical cases and practical experience from a leading nuclear medicine department. The speakers demonstrate a systematic approach to quality control, but the content is largely anecdotal and lacks formal citations or peer-reviewed references.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of the session on quality control in nuclear medicine.
• 01:00Case 1: PRRT therapy patients with abnormal bone uptake; investigation of TLC results.
• 05:00Case 1 continued: TLC results show single peak but Rf value differs; heating block issue identified.
• 10:00Case 2: Ga-68 DOTATOC scan showing blood pool distribution; TLC similar but pH difference found.
• 15:00Discussion on the importance of understanding Rf values and process QC.
• 20:00Overview of QC tests: physical, chemical, radionuclide purity, endotoxin, sterility.
• 25:00Detailed explanation of TLC procedure and Rf calculation.
• 30:00Chemical purity testing for FDG using spot test kits.
• 35:00Radionuclide purity testing via half-life measurement and gamma spectrometry.
• 40:00Q&A session on GMP regulations and spot test kits.

• Korean Pharmacopoeia — Mentioned as a reference for QC standards.
• USP 32-NF 27 — Mentioned as a reference for QC standards.

• IAEA Quality Control of Radiopharmaceuticals — International guidelines on QC for radiopharmaceuticals, consistent with the presentation's emphasis.